Affiliation:
1. The First Affiliated Hospital of Guangzhou Medical University
Abstract
Abstract
Purpose
Worldwide, colon cancer (CC) is one of the most commonly occurring malignancies. However, the molecular basis of the pathogenesis of CRC needs to be further explored. Studies have demonstrated that the chaperonin-containing TCP1 (CCT) complex contributes to the development and progression of various tumors. However, the functional significance of CCT in CC is unclear.
Methods
This study explored the potential functions of CCT family genes in CC by bioinformatics analysis. In addition, we established a risk score model based on the CCT family genes, which was validated to effectively predict the prognosis of CC patients.
Results
We found that CCTA6, one of the CCT family genes, was significantly more highly expressed in CC tissues than in normal tissues, and that increased expression of CCT6A was associated with a lower survival rate in CC patients. These findings were validated by real-world data.
Conclusion
Through the preliminary exploration of the role of CCT family genes in CC in this study, we found that CCT6A may contribute significantly in CC, and thus this gene may be an attractive therapeutic target for CC patients.
Publisher
Research Square Platform LLC
Reference41 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021
2. Vet al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making;Schmoll HJ;Ann Oncol,2012
3. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set;O'Connell MJ;J Clin Oncol,2008
4. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study;Fitzmaurice C;JAMA Oncol,2018
5. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Labianca R;Ann Oncol,2013